By Susan Young, MIT Technology Review, www.technologyreview.com
A new kind of artificial heart that combines synthetic and biological materials as well as sensors and software to detect a patient’s level of exertion and adjust output accordingly is to be tested in patients at four cardiac surgery centers in Europe and the Middle East. If the “bioprosthetic” device, made by the Paris-based Carmat, proves to be safe and effective, it could be given to patients waiting for a heart transplant.
Latest from Today's Medical Developments
- Stryker’s flexible syndesmotic fixation device stabilizes ankle injuries
- Mergers & acquisitions news: MGS, Quantum Surgical bolster medtech portfolios
- Exchangeable-head solid carbide cutting tools
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
